• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:家族性多发性内分泌腺瘤病 1 型中新型胚系 c.587delA 致病性变异。

Case report: Novel germline c.587delA pathogenic variant in familial multiple endocrine neoplasia type 1.

机构信息

School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Endocrinol (Lausanne). 2024 Sep 20;15:1467882. doi: 10.3389/fendo.2024.1467882. eCollection 2024.

DOI:10.3389/fendo.2024.1467882
PMID:39371924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11452907/
Abstract

Multiple Endocrine Neoplasia type 1 () is a rare genetic disease, characterized by co-occurrence of several lesions of the endocrine system. In , the pathogenic gene mutations lead to the Abnormal expression of menin, a critical tumor suppressor protein. We here reported a case of a 14-year-old male with insulinoma and primary hyperparathyroidism. Genetic testing demonstrated a novel heterozygote variant c.587delA of MEN1, resulting in the substitution of the 196th amino acid, changing from glutamic acid to glycine, followed by a frameshift translation of 33 amino acids. An identical variant was identified in the proband's father, who was further diagnosed with hyperparathyroidism. To the best of our knowledge, this is the first report of MEN1 syndrome caused by the c.587delA MEN1 variant. Observations indicated that, despite sharing the same MEN1 gene change, family members exhibited diverse clinical phenotypes. This underscored the presence of genetic anticipation within the familial context.

摘要

多发性内分泌腺瘤病 1 型()是一种罕见的遗传性疾病,其特征是内分泌系统的几种病变同时发生。在这种疾病中,致病基因突变导致关键肿瘤抑制蛋白门冬酰胺酶异常表达。我们在此报告一例 14 岁男性胰岛素瘤和原发性甲状旁腺功能亢进症患者。基因检测显示 MEN1 的新型杂合子变体 c.587delA,导致第 196 位氨基酸的取代,由谷氨酸变为甘氨酸,并随后进行 33 个氨基酸的移码翻译。该变异在先证者的父亲中也被鉴定出来,他随后被诊断为甲状旁腺功能亢进症。据我们所知,这是首例由 c.587delA MEN1 变体引起的 MEN1 综合征报告。观察结果表明,尽管家族成员共享相同的 MEN1 基因突变,但表现出不同的临床表型。这表明在家族背景下存在遗传预期。

相似文献

1
Case report: Novel germline c.587delA pathogenic variant in familial multiple endocrine neoplasia type 1.病例报告:家族性多发性内分泌腺瘤病 1 型中新型胚系 c.587delA 致病性变异。
Front Endocrinol (Lausanne). 2024 Sep 20;15:1467882. doi: 10.3389/fendo.2024.1467882. eCollection 2024.
2
Novel Germline c.105_107dupGCT Mutation in a Family with Newly Diagnosed Multiple Endocrine Neoplasia Type 1.家族性新诊断的多发性内分泌腺瘤病 1 型中存在新型种系 c.105_107dupGCT 突变。
Genes (Basel). 2020 Aug 24;11(9):986. doi: 10.3390/genes11090986.
3
Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.利用全外显子组测序对1型多发性内分泌肿瘤患者的甲状旁腺和胰腺肿瘤进行基因分析。
BMC Med Genet. 2017 Oct 2;18(1):106. doi: 10.1186/s12881-017-0465-9.
4
A novel six-nucleotide insertion in exon 4 of the MEN1 gene, 878insCTGCAG, in three patients with familial insulinoma and primary hyperparathyroidism.
Jpn J Clin Oncol. 2002 Sep;32(9):368-70. doi: 10.1093/jjco/hyf079.
5
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.1型多发性内分泌腺瘤(MEN1):对该基因被鉴定后的首个十年内报告的1336个突变的分析
Hum Mutat. 2008 Jan;29(1):22-32. doi: 10.1002/humu.20605.
6
A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.一个 MEN1 家族中的胚系 c.1546dupC MEN1 突变:病例报告。
Medicine (Baltimore). 2021 Jun 25;100(25):e26382. doi: 10.1097/MD.0000000000026382.
7
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.家族性1型多发性内分泌肿瘤及相关病症中MEN1基因的种系突变。
Hum Mol Genet. 1997 Jul;6(7):1169-75. doi: 10.1093/hmg/6.7.1169.
8
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas.一种 MEN1 基因的新型可能致病变异 p.(Cys235Arg) 与多灶性胰高血糖素瘤相关的 1 型多发性内分泌肿瘤。
J Endocrinol Invest. 2024 Jul;47(7):1815-1825. doi: 10.1007/s40618-023-02287-x. Epub 2024 Jan 31.
9
Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.散发性胰腺内分泌肿瘤中p27(CDKN1B)和p18(CDKN2C)的突变分析不支持其肿瘤抑制功能。
Neoplasia. 2007 Jul;9(7):533-5. doi: 10.1593/neo.07328.
10
Identification of a novel frameshift c.930delG MEN1 germline mutation (p.Glu273LysfsTer7) in a sporadic case of multiple endocrine neoplasia type 1: A case report.鉴定出一例散发性 1 型多发性内分泌肿瘤的新型移码突变 c.930delG MEN1 种系突变(p.Glu273LysfsTer7):一例病例报告。
Mol Med Rep. 2020 Dec;22(6):5423-5427. doi: 10.3892/mmr.2020.11596. Epub 2020 Oct 14.

本文引用的文献

1
French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d'étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1.法国内分泌肿瘤研究小组/法国内分泌外科学会/国家内分泌肿瘤治疗网络(GTE、AFCE和ENDOCAN-RENATEN)关于1型多发性内分泌腺瘤病筛查、诊断及管理的指南。
Ann Endocrinol (Paris). 2024 Feb;85(1):2-19. doi: 10.1016/j.ando.2023.09.003. Epub 2023 Sep 20.
2
Multiple Endocrine Neoplasia Type 1: Latest Insights.多发性内分泌腺瘤病 1 型:最新见解。
Endocr Rev. 2021 Mar 15;42(2):133-170. doi: 10.1210/endrev/bnaa031.
3
Novel Germline c.105_107dupGCT Mutation in a Family with Newly Diagnosed Multiple Endocrine Neoplasia Type 1.
家族性新诊断的多发性内分泌腺瘤病 1 型中存在新型种系 c.105_107dupGCT 突变。
Genes (Basel). 2020 Aug 24;11(9):986. doi: 10.3390/genes11090986.
4
A novel MEN1 pathogenic variant in an Italian patient with multiple endocrine neoplasia type 1.一名意大利 1 型多发性内分泌肿瘤患者的 MEN1 致病性新变异。
Mol Biol Rep. 2020 Sep;47(9):7313-7316. doi: 10.1007/s11033-020-05730-x. Epub 2020 Aug 17.
5
The future: genetics advances in MEN1 therapeutic approaches and management strategies.未来:MEN1 治疗方法和管理策略中的遗传学进展。
Endocr Relat Cancer. 2017 Oct;24(10):T119-T134. doi: 10.1530/ERC-17-0199.
6
Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years.1型多发性内分泌腺瘤病(MEN1):过去九年报告的208种新种系变体的最新情况。
Cancer Genet. 2016 Jan-Feb;209(1-2):36-41. doi: 10.1016/j.cancergen.2015.12.002. Epub 2015 Dec 14.
7
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).《多发性内分泌肿瘤 1 型(MEN1)临床实践指南》。
J Clin Endocrinol Metab. 2012 Sep;97(9):2990-3011. doi: 10.1210/jc.2012-1230. Epub 2012 Jun 20.
8
Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.具有种系 MEN1 疾病基因突变的患者的可变临床表达:基因型-表型相关性的线索。
Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):49-56. doi: 10.6061/clinics/2012(sup01)10.
9
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.1型多发性内分泌腺瘤(MEN1):对该基因被鉴定后的首个十年内报告的1336个突变的分析
Hum Mutat. 2008 Jan;29(1):22-32. doi: 10.1002/humu.20605.
10
The treatment of sporadic versus MEN1-related pituitary adenomas.散发性与MEN1相关垂体腺瘤的治疗。
J Intern Med. 2003 Jun;253(6):599-605. doi: 10.1046/j.1365-2796.2003.01164.x.